American Association for Cancer Research (AACR)
-
Publisher Of
-
Radiation Sensitivity in a Preclinical Mouse Model of Medulloblastoma Relies on the Function of the Intrinsic Apoptotic Pathway.
Cancer Research.
76:3211-3223.
2016
-
Recurrent Mutations of Chromatin-Remodeling Genes and Kinase Receptors in Pheochromocytomas and Paragangliomas.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research.
22:2301-2310.
2016
-
Anti-Mullerian Hormone Concentrations in Premenopausal Women and Breast Cancer Risk.
Cancer Prevention Research.
8:528-534.
2015
-
CSF1 Receptor Targeting in Prostate Cancer Reverses Macrophage-Mediated Resistance to Androgen Blockade Therapy.
Cancer Research.
75:950-962.
2015
-
p53 Mutation Directs AURKA Overexpression via
miR-25
and FBXW7 in Prostatic Small Cell Neuroendocrine Carcinoma.
Molecular Cancer Research : Mcr.
13:584-591.
2015
-
Abstract IA08: Ataxia-telangiectasia: Broad implications from the study of a rare disease.
Cancer Research.
74:IA08-IA08.
2014
-
Epigenetic States of Cells of Origin and Tumor Evolution Drive Tumor-Initiating Cell Phenotype and Tumor Heterogeneity.
Cancer Research.
74:4864-4874.
2014
-
Aggressive Variants of Castration-Resistant Prostate Cancer.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research.
20:2846-2850.
2014
-
Abstract P1-08-20: Increased risk of hormone therapy failure in breast cancers expressing low phospho-Stat5: Validation of quantitative immunofluorescence assay parameters.
Cancer Research.
73.
2013
-
Abstract P4-06-03: Assays on core biopsies and surgically resected tumors may result in different subtyping of the invasive breast cancer from the same patient.
Cancer Research.
73.
2013
-
Abstract P4-06-09: HER2+ and HER2- luminal B subtypes have similar overall survival and histologic grade distributions.
Cancer Research.
73.
2013
-
Abstract P4-15-05: Novel targeted therapy for breast cancer chest wall recurrence: Low temperature liposomal doxorubicin and mild local hyperthermia.
Cancer Research.
73.
2013
-
Abstract P5-08-01: Systematic interrogation of resistance to HER2-directed therapy identifies a survival pathway activated by PRKACA and PIM1.
Cancer Research.
73.
2013
-
S100A14: Novel Modulator of Terminal Differentiation in Esophageal Cancer.
Molecular Cancer Research : Mcr.
11:1542-1553.
2013
-
Notch1-Induced Brain Tumor Models the Sonic Hedgehog Subgroup of Human Medulloblastoma.
Cancer Research.
73:5381-5390.
2013
-
Animal Models of Human Prostate Cancer: The Consensus Report of the New York Meeting of the Mouse Models of Human Cancers Consortium Prostate Pathology Committee.
Cancer Research.
73:2718-2736.
2013
-
Abstract 1199: NSCLC KRAS G12C and G12V mutations drive different pathways and display specific drug sensitivity patterns..
Cancer Research.
73:1199-1199.
2013
-
Abstract 2409: A model of RAS pathway in colorectal cancer elucidates molecular traits and drug sensitivity: an integrated analysis of gene expression from human tumors, mouse xenografts and the Cancer Cell Line Encyclopedia (CCLE)..
Cancer Research.
73:2409-2409.
2013
-
Hyperactivated JNK Is a Therapeutic Target in pVHL-Deficient Renal Cell Carcinoma.
Cancer Research.
73:1374-1385.
2013
-
Abstract PR3: The cholesterol metabolite 27-hydroxycholesterol increases breast cancer tumor growth and metastasis.
Cancer Research.
73:PR3-PR3.
2013
-
Abstract A29: An Ad5 [E1-, E2b-] platform carrying the TAA CEA(6D) induces CEA directed CMI responses in patients with advanced CEA-expressing colorectal cancer in a phase I/II clinical trial...
Cancer Research.
73:A29-A29.
2013
-
Abstract P2-10-03: A cross-platform comparison of genomic signatures and OncotypeDx score to discover potential prognostic/predictive genes and pathways.
Cancer Research.
72.
2012
-
Abstract P3-06-07: Ki67 as a Predictive Marker of Response to Neoadjuvant Chemotherapy in Patients with Early-Stage Breast Cancer (ESBC): A Systematic Review and Evidence Summary.
Cancer Research.
72.
2012
-
Abstract P4-08-07: Novel insight into the tumor “flare” phenomenon and lapatinib resistance.
Cancer Research.
72.
2012
-
Abstract P4-14-04: Total skin-sparing mastectomy in BRCA mutation carriers.
Cancer Research.
72.
2012
-
Abstract P4-16-07: Selective use of post-mastectomy radiation therapy in the neoadjuvant setting.
Cancer Research.
72.
2012
-
Cross-talk between HER2 and MED1 Regulates Tamoxifen Resistance of Human Breast Cancer Cells.
Cancer Research.
72:5625-5634.
2012
-
Combination of Rad001 (Everolimus) and Propachlor Synergistically Induces Apoptosis through Enhanced Autophagy in Prostate Cancer Cells.
Molecular Cancer Therapeutics.
11:1320-1331.
2012
-
Abstract 1369: Mouse models of clinical oligo- and poly-metastatic progression.
Cancer Research.
72:1369-1369.
2012
-
Abstract 1563:In vivosafety and efficacy of a novel dendritic cell based Ad-GMCAIX vaccine with activity against renal cell carcinoma.
Cancer Research.
72:1563-1563.
2012
-
Abstract 1678: European ancestry and ovarian cancer: Testing for their association using case control data.
Cancer Research.
72:1678-1678.
2012
-
Abstract 2012: MAP kinase activation and suppression of anti-apoptotic Bcl-2 family members are associated with induction of apoptotic death in melanoma cells following down-regulation of glutathione S-transferase P1.
Cancer Research.
72:2012-2012.
2012
-
Abstract 2162: EGFR-induced interaction of GSTP1 with the SH2-domain of Grb2 enhances Ras downstream activation in human glioma cells.
Cancer Research.
72:2162-2162.
2012
-
Abstract 2603: Subtype-specific ovarian cancer risk associated with SNPs inIL1A.
Cancer Research.
72:2603-2603.
2012
-
Abstract 2884: Preclinical studies on tumor retention, antitumor efficacy and toxicity of thermally responsive polypeptide-based radionuclide intratumoral depot in nude mice.
Cancer Research.
72:2884-2884.
2012
-
Abstract 2923: Androgen receptor activation changes chromatin structure and transcriptional activation.
Cancer Research.
72:2923-2923.
2012
-
Abstract 2992: Analysis of divergent hypoxic gene expression data in prostate cancer cell lines suggests novel tumor progression biomarkers.
Cancer Research.
72:2992-2992.
2012
-
Abstract 3035: Bone morphogenetic proteins signal through Smad2 and Smad3 to regulate cell migration and proliferation.
Cancer Research.
72:3035-3035.
2012
-
Abstract 3220: The effects of cholesterol treatment drugs alone and in combination on prostate tumor xenograft growth.
Cancer Research.
72:3220-3220.
2012
-
Abstract 3405: MicroRNA expression characterizes oligometastasis(es).
Cancer Research.
72:3405-3405.
2012
-
Abstract 381: Non-invasive histology for early detection of cutaneous melanoma and pigmented lesionsin vivo.
Cancer Research.
72:381-381.
2012
-
Abstract 4311: EphB2 receptor controls proliferation/migration dichotomy of glioblastoma by interacting with focal adhesion kinase.
Cancer Research.
72:4311-4311.
2012
-
Abstract 4389: Impact of regulatory T cell depletion on dendritic cell-tumor fusion vaccine immunotherapy.
Cancer Research.
72:4389-4389.
2012
-
Abstract 4514: A comparison of two methodologies to quantify Thymidylate synthase for predicting survival in patients with colorectal cancer treated on CALGB 89803.
Cancer Research.
72:4514-4514.
2012
-
Abstract 4812: p53 acts during total-body irradiation to promote lymphomagenesis.
Cancer Research.
72:4812-4812.
2012
-
Abstract 4958: Identification of cis-regulatory elements in a BIM deletion polymorphism that regulate splicing and generation of non-apoptotic BIM isoforms.
Cancer Research.
72:4958-4958.
2012
-
Abstract 5123: An integrated genomics approach to identify novel drivers of oncogenic pathway activity in human cancer.
Cancer Research.
72:5123-5123.
2012
-
Abstract 530: Circulating γδ T cells are activated and depleted during progression of high-grade gliomas: Implications for γδ T cells therapy of GBM.
Cancer Research.
72:530-530.
2012
-
Abstract 5363: Aggregation rather than monoclonal expansion explains ovarian cancer spheroid formation.
Cancer Research.
72:5363-5363.
2012
-
Abstract 5373: Altering the composition of the proteasome of melanoma antigen RNA-transfected dendritic cells enhances vaccination-induced anti-melanoma immunity: results of a Phase I trial.
Cancer Research.
72:5373-5373.
2012
-
Abstract LB-154: Nuclear export of CALM-AF10 is essential for leukemogenesis.
Cancer Research.
72.
2012
-
Abstract LB-327: Validation of a breast cancer risk prediction model in African American women.
Cancer Research.
72.
2012
-
Abstract LB-76: Mibefradil, a novel therapy for glioblastoma: An interlaced therapy approach.
Cancer Research.
72.
2012
-
Abstract LB-87: Methylated-mediated repression ofZNF154in ovarian cancer is associated with poor overall survival.
Cancer Research.
72.
2012
-
Pten Loss and RAS/MAPK Activation Cooperate to Promote EMT and Metastasis Initiated from Prostate Cancer Stem/Progenitor Cells.
Cancer Research.
72:1878-1889.
2012
-
P1-01-15: Do Serum Cytokines Predict Breast Cancer Behavior?.
Cancer Research.
71.
2011
-
P1-06-24: Nuclear Localization of Stat5a Predicts Response to Antiestrogen Therapy and Prognosis of Clinical Breast Cancer Outcome..
Cancer Research.
71.
2011
-
P1-13-03: Zoledronic Acid Induces an Immune Response in Breast Cancer Patients through Stimulation of Central Memory and Effector Memory gamma/delta T-Cells..
Cancer Research.
71.
2011
-
P3-14-04: Assessment of Genomic Prognostic Signatures as Predictors of Response to Neoadjuvant Chemotherapy in Patients with Early Stage Breast Cancer..
Cancer Research.
71.
2011
-
Definition of a FoxA1 Cistrome That Is Crucial for G1 to S-Phase Cell-Cycle Transit in Castration-Resistant Prostate Cancer.
Cancer Research.
71:6738-6748.
2011
-
Correction: Aggressive Fibromatosis (Desmoid Tumor) Is Derived from Mesenchymal Progenitor Cells.
Cancer Research.
71:6084-6084.
2011
-
CCI-779 Inhibits Cell-Cycle G2-M Progression and Invasion of Castration-Resistant Prostate Cancer via Attenuation of UBE2C Transcription and mRNA Stability.
Cancer Research.
71:4866-4876.
2011
-
Abstract 1635: Short hairpin RNA-mediated transcriptional suppression of glutathione S-transferase P1 suppresses growth and induces apoptosis through altered MAP kinase signaling in melanoma cells.
Cancer Research.
71:1635-1635.
2011
-
Abstract 2277: Loss of nuclear localized and tyrosine phosphorylated Stat5: A predictor of poor clinical outcome and increased risk of antiestrogen therapy failure in breast cancer.
Cancer Research.
71:2277-2277.
2011
-
Abstract 2337: Defining significance of the novel tGLI1 transcription factor in cancer growth and progression.
Cancer Research.
71:2337-2337.
2011
-
Abstract 2482: Bat3 facilitates histone H3 lysine 79 dimethylation by DOT1L to promote ionizing radiation-induced 53BP1 foci formation during G1- and G2-phases of the cell cycle.
Cancer Research.
71:2482-2482.
2011
-
Abstract 2754: Maternal use of antidepressants in pregnancy is associated with hypermethylation at theIGF2imprinted control regions in the offspring in a race-dependent fashion.
Cancer Research.
71:2754-2754.
2011
-
Abstract 2767: Genetic variation in obesity-related genes ADBR2, ADBR3, GHRL, HSD11B1, and SHC1 and risk of prostate cancer: A VA case-control study.
Cancer Research.
71:2767-2767.
2011
-
Abstract 2817: An RNA aptamer is a potential biomarker for pancreatic cancer.
Cancer Research.
71:2817-2817.
2011
-
Abstract 3014: Quantitative accuracy of Illumina HumanMethylation27 Infinium BeadChip data assessed by pyrosequencing.
Cancer Research.
71:3014-3014.
2011
-
Abstract 3086: Interactions of nucleolin and ribosomal protein RPL26 in the translational control of human p53 mRNA.
Cancer Research.
71:3086-3086.
2011
-
Abstract 3311: IL6-Stat3 signaling promotes glioma stem cell (GSC) survival under hypoxia environment through inhibition of cell-death inducing gene Bnip3.
Cancer Research.
71:3311-3311.
2011
-
Abstract 4417: Characterization of xenograft-derived EGFRvIII-positive GBM cell cultures reveals functional interactions between EGFRvIII, wild-type EGFR, and p53.
Cancer Research.
71:4417-4417.
2011
-
Abstract 4602: Cholesterol and ezetimibe: Effects on tumor growth and survival outcomes: An interim analysis.
Cancer Research.
71:4602-4602.
2011
-
Abstract 4637: Intra-individual changes in circulating IGF-1 and IGF-1/IGFBP-3 molar ratio are associated with colorectal adenomatous polyps presence.
Cancer Research.
71:4637-4637.
2011
-
Abstract 4697: Metabolic regulation of caspase-2.
Cancer Research.
71:4697-4697.
2011
-
Abstract 5306:18F-EF5 microPET imaging of treatment response from a novel, hypoxia-selective cytotoxin SN30000 in a human lung cancer xenograft model.
Cancer Research.
71:5306-5306.
2011
-
Abstract 615: PP2A activation as a strategy for treatment of breast cancer.
Cancer Research.
71:615-615.
2011
-
Abstract 703: GSTP1 inhibition of HSP27 phosphorylation contributes to glioma drug resistance.
Cancer Research.
71:703-703.
2011
-
Abstract LB-255: A mass spectrometry platform to quantitatively profile cancer cell metabolism from cells, tumors, and fixed tissue.
Cancer Research.
71.
2011
-
Abstract LB-454: Serum metabolic profiles and endometrial cancer.
Cancer Research.
71.
2011
-
Invasive Prostate Carcinoma Driven by c-Src and Androgen Receptor Synergy.
Cancer Research.
71:862-872.
2011
-
Abstract P1-04-01: X-Linked Inhibitor of Apoptosis Protein (XIAP) Regulates TRAIL-Induced Apoptosis in Inflammatory Breast Cancer Cells.
Cancer Research.
70.
2010
-
Abstract P2-12-01: Is Cancer-Specific Distress Correlated with Time to Definitive Surgery in Breast Cancer Patients?.
Cancer Research.
70.
2010
-
Abstract P5-14-03: The Impact of Routine Cavity Margins on Reducing the Need for Re-Excision in Women Undergoing Breast-Conserving Surgery for Invasive or Non-Invasive Breast Cancer.
Cancer Research.
70.
2010
-
Abstract P6-01-01: Risk of Invasive Breast Cancer and Ductal Carcinoma In-Situ in Women with Atypical Papillary Lesions of the Breast.
Cancer Research.
70.
2010
-
Prognostic Value and Function of KLF4 in Prostate Cancer: RNAa and Vector-Mediated Overexpression Identify KLF4 as an Inhibitor of Tumor Cell Growth and Migration.
Cancer Research.
70:10182-10191.
2010
-
CXCR2 Promotes Ovarian Cancer Growth through Dysregulated Cell Cycle, Diminished Apoptosis, and Enhanced Angiogenesis.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research.
16:3875-3886.
2010
-
Abstract 3971: The type III tgf-β receptor mediates bmp signaling in normal and cancerous mammary epithelial cells.
Cancer Research.
70:3971-3971.
2010
-
Abstract 4831: ATM signals to TSC2 in the cytoplasm to regulate mTORC1 and autophagy in response to ROS.
Cancer Research.
70:4831-4831.
2010
-
Abstract 5061: Induction of B cell acute lymphoblastic leukemia by BCR/ABL requires c-Myb and its activation of Bmi-1.
Cancer Research.
70:5061-5061.
2010
-
Abstract 5338: Metastatic colorectal cancer cells from patients previously treated with chemotherapy are sensitive to T cell killing mediated by CEA/CD3-bispecific T cell-engaging BiTE antibody.
Cancer Research.
70:5338-5338.
2010
-
Abstract LB-213: Plasma soluble VEGFR1 is a potential dual biomarker of response and toxicity for bevacizumab with chemoradiation in locally advanced rectal cancer.
Cancer Research.
70.
2010
-
Ionizing Radiation Induces Prostate Cancer Neuroendocrine Differentiation through Interplay of CREB and ATF2: Implications for Disease Progression.
Cancer Research.
68:9663-9670.
2008
-
The natural product honokiol preferentially inhibits cellular FLICE-inhibitory protein and augments death receptor-induced apoptosis.
Molecular Cancer Therapeutics.
7:2212-2223.
2008
-
Genome-Wide Impact of Androgen Receptor Trapped clone-27 Loss on Androgen-Regulated Transcription in Prostate Cancer Cells.
Cancer Research.
69:3140-3147.
-
The Role of microRNA-221 and microRNA-222 in Androgen-Independent Prostate Cancer Cell Lines.
Cancer Research.
69:3356-3363.
-
Abstract 1859: Hsp90 targeted near infrared molecular imaging to detect mammografically occult invasive lobular breast cancer.
Cancer Research.
1859-1859.
2017
-
Abstract 2272: A prospective study of urinary prostaglandin E2 metabolite,Helicobacter pyloriantibodies, and gastric cancer risk.
Cancer Research.
2272-2272.
2017
-
Abstract 2810: Using CRISPR/Cas9 to generate primary soft tissue sarcoma in genetically engineered and wild-type mice.
Cancer Research.
2810-2810.
2017
-
Abstract 4709: Induction of enhanced tumor-specific immunity by Hsp90 targeted photodynamic therapy (Hsp90-PDT) combined with immune checkpoint inhibition.
Cancer Research.
4709-4709.
2017
-
Abstract 5830: A novel Notch-YAP circuit drives stemness and tumorigenesis in embryonal rhabdomyosarcoma.
Cancer Research.
5830-5830.
2017
-
Abstract 588: Advanced molecular characterization of severe autoimmune toxicities associated with checkpoint inhibitor therapies.
Cancer Research.
588-588.
2017
-
Abstract OT1-04-06: NRG-BR002: A phase IIR/III trial of standard of care therapy with or without stereotactic body radiotherapy (SBRT) &/or surgical ablation for newly oligometastatic breast cancer.
Cancer Research.
2017
-
Abstract P1-01-01: Circulating tumor cell number and CTC-endocrine therapy index predict clinical outcomes in ER positive metastatic breast cancer patients: Results of the COMETI Phase 2 trial.
Cancer Research.
2017
-
Abstract P1-05-30: Genomic and microenvironmental intra-tumor heterogeneity in DCIS.
Cancer Research.
2017
-
Abstract P1-06-06: Evidence for tumor heterogeneity and clonal evolution during invasive progression of breast cancer.
Cancer Research.
2017
-
Abstract P2-04-19: Elucidating the tumor immune microenvironment phenotype in early stage untreated BRCA mutated breast cancer patients.
Cancer Research.
2017
-
Abstract P2-04-27: CTLA-4 and PD-1 checkpoint inhibitors enhance individually tailored adaptive anti-tumor immune responses to overcome tumor immunosuppression and effectively treat triple-negative breast cancer.
Cancer Research.
2017
-
Abstract P3-07-14: Targeting ERR-α regulated lactate metabolism eliminates drug-resistant breast cancer cells.
Cancer Research.
2017
-
Abstract P3-16-02: Nanotheranostics using plasmonic gold nanostars to target inflammatory breast cancer cells and tumor emboli.
Cancer Research.
2017
-
Abstract P5-08-12: HER2 status remains the primary predictor of improved survival in patients with BCBM over the past 2 decades (1996-2015).
Cancer Research.
2017
-
Abstract PD1-03: Multivariate analysis of subtype and gene expression signatures predictive of pathologic complete response (pCR) in triple-negative breast cancer (TNBC): CALGB 40603 (Alliance).
Cancer Research.
2017
-
Abstract S3-05: Integrated analysis of multidimensional genomic data on CALGB 40601 (Alliance), a randomized neoadjuvant phase III trial of weekly paclitaxel (T) and trastuzumab (H) with or without lapatinib (L) for HER2-positive breast cancer.
Cancer Research.
2017
-
Abstract 1182: Heparin-binding epidermal growth factor-like growth factor is a pro-differentiating factor in neuroblastoma.
Cancer Research.
1182-1182.
2016
-
Abstract 1735: Fruit and vegetable consumption and risk of gastric cancer: a prospective nested case-control study in China, Japan and Korea.
Cancer Research.
1735-1735.
2016
-
Abstract 1754: Body powder use and ovarian cancer: the African American Cancer Epidemiology Study.
Cancer Research.
1754-1754.
2016
-
Abstract 2037: A discovery study to identify clinical and genetic risk factors for bevacizumab (BEV)-related gastrointestinal (GI) hemorrhage (HEM) in metastatic castration-resistant prostate cancer (mCRPC) patients (pts) treated on CALGB 90401 (Alliance).
Cancer Research.
2037-2037.
2016
-
Abstract 3388: Genetic prediction of VEGF-A plasma levels in cancer patients.
Cancer Research.
3388-3388.
2016
-
Abstract 3407: Gene expression subtypes of high grade serous ovarian cancer in African American women.
Cancer Research.
3407-3407.
2016
-
Abstract 3417: Peripheral CD8+CD28-suppressive T lymphocytes act as a prognosticator among breast cancer patients with adoptive T-cell immunotherapy.
Cancer Research.
3417-3417.
2016
-
Abstract 797: A splicing variant of TERT identified by GWAS interacts with menopausal estrogen therapy in risk of ovarian cancer.
Cancer Research.
797-797.
2016
-
Abstract LB-015: XIAP induction by the MAPK-eIF4G1 pathway drives NFκB activation in inflammatory breast cancer growth and therapeutic resistance.
Cancer Research.
2016
-
Abstract LB-361: Serology of Streptococcus gallolyticus subsp. gallolyticus and risk of colorectal cancer.
Cancer Research.
2016
-
Abstract ES8-3: Endocrine management of premalignant lesions and DCIS.
Cancer Research.
2016
-
Abstract OT3-03-04: NRG-BR002: A phase IIR/III trial of standard of care therapy with or without stereotactic body radiotherapy (SBRT) &/or surgical ablation for newly oligometastatic breast cancer.
Cancer Research.
2016
-
Abstract P3-14-04: Effects of the dual selective CYP17 lyase inhibitor and androgen receptor (AR) antagonist, VT-464, on AR+ and ER+ tumor models in vitro and in vivo.
Cancer Research.
2016
-
Abstract P4-08-03: DEAD-box RNA helicase DP103 as a novel regulator of Wnt/β-catenin signaling pathway and promotes cancer stem cell-like behavior in triple negative breast cancers.
Cancer Research.
2016
-
Abstract P4-09-16: A monoclonal antibody with exceptional specificity across major breast cancer subtypes.
Cancer Research.
2016
-
Abstract P4-14-16: T-cell clonality increases after neoadjuvant treatment with trastuzumab and pertuzumab.
Cancer Research.
2016
-
Abstract P5-17-03: The 12-gene DCIS score assay: Impact on radiation treatment (XRT) recommendations and clinical utility.
Cancer Research.
2016
-
Abstract P6-05-03: Genomic diversity of ductal carcinoma in situ (DCIS) as a driver of invasion and metastasis.
Cancer Research.
2016
-
Abstract S3-06: Treatment outcomes in patients with invasive breast cancer treated with neoadjuvant systemic therapy and breast MR imaging: Results of a secondary analysis of TBCRC 017.
Cancer Research.
2016
-
Abstract 1100: Functional genomics to investigate the genetic determinants of cell death induced by oxidative stresses.
Cancer Research.
1100-1100.
2015
-
Abstract 1585: Application of a graphene oxide based microfluidic device (GO Chip) to prostate cancer circulating tumor cell capture and analysis.
Cancer Research.
1585-1585.
2015
-
Abstract 1610: Development of meta-[211At]astatobenzylguanidine ([211At]MABG) as an alpha particle emitting systemic targeted radiotherapeutic for neuroblastoma.
Cancer Research.
1610-1610.
2015
-
Abstract 1809: Next-generation brachytherapy: a preclinical study of a thermally stabilized biopolymer gel for delivering intratumoral radionuclide therapy in a pancreatic tumor mouse model.
Cancer Research.
1809-1809.
2015
-
Abstract 1847: AR-V7 regulation during epithelial plasticity.
Cancer Research.
1847-1847.
2015
-
Abstract 2236: Emergence of epigenetic regulation of tight junction genes in recurrent serous epithelial ovarian cancer.
Cancer Research.
2236-2236.
2015
-
Abstract 2703: Overcoming Lapatinib resistance by the fatty acid synthase inhibitor HS-106.
Cancer Research.
2703-2703.
2015
-
Abstract 2891: Chemokine-targeted models of human orthotopic colorectal cancer in immunocompetant mice.
Cancer Research.
2891-2891.
2015
-
Abstract 3004: Contextual RNAi screen identifies ACLY and ACC1 as mediators of hypoxia-induced apoptosis through metabolic and transcriptional mechanisms.
Cancer Research.
3004-3004.
2015
-
Abstract 3212: Metastatic breast cancer cell communication within a pro-dormancy bone marrow niche.
Cancer Research.
3212-3212.
2015
-
Abstract 3302: Subtype-specific radiation response in a mouse model of human breast cancer.
Cancer Research.
3302-3302.
2015
-
Abstract 3331: Gene expression profiling after radiation in human breast cancer specimens and breast cancer cell lines.
Cancer Research.
3331-3331.
2015
-
Abstract 3732: Detecting germline PTEN mutations among at-risk cancer patients: An age and gender-specific cost effectiveness analysis.
Cancer Research.
3732-3732.
2015
-
Abstract 4449: A novel Porcupine inhibitor is effective in the treatment of cancers with RNF43 mutations.
Cancer Research.
4449-4449.
2015
-
Abstract 4597: A novel variant in DNA repair gene GTF2H4 is associated with lung cancer risk: A reanalysis of GWAS datasets from the TRICL consortium.
Cancer Research.
4597-4597.
2015
-
Abstract 4633: Evidence that long non-coding RNA variants associate with epithelial ovarian cancer risk.
Cancer Research.
4633-4633.
2015
-
Abstract 4634: Variants within super-enhancer regulatory elements associate with epithelial ovarian cancer risk.
Cancer Research.
4634-4634.
2015
-
Abstract 4635: Inherited variants affecting RNA editing may contribute to ovarian cancer susceptibility.
Cancer Research.
4635-4635.
2015
-
Abstract 4636: Investigation of exome variants associated with overall survival in ovarian cancer.
Cancer Research.
4636-4636.
2015
-
Abstract 5465: Systematic interrogation of druggable pathways in pancreatic adenocarcinomas using pooled gene-knockdown lentiviral libraries.
Cancer Research.
5465-5465.
2015
-
Abstract 891: FGF21 prevents high fat diet-induced pancreatic cancer in mice expressing oncogenic Kras.
Cancer Research.
891-891.
2015
-
Abstract LB-087: A facilitative role for caspase 3 in promoting genetic instability and carcinogenesis.
Cancer Research.
2015
-
Abstract SY36-03: Intraoperative molecular imaging with protease-activated fluorescent imaging agents.
Cancer Research.
2015
-
Abstract P1-10-02: Adjuvant radiation after lumpectomy: A cost comparison of treatment patterns in 43,247 women from the National Cancer Data Base.
Cancer Research.
2015
-
Abstract P1-10-04: Post-operative imaging after atypical ductal hyperplasia excision: The findings and costs.
Cancer Research.
2015
-
Abstract P1-15-10: Low utilization of hypofractionated radiotherapy for the treatment of early-stage breast cancer in the US.
Cancer Research.
2015
-
Abstract P2-12-07: The association between exercise behavior and patient-reported outcomes in women with early breast cancer receiving locoregional radiation therapy.
Cancer Research.
2015
-
Abstract P3-07-22: Predictors of neoadjuvant chemotherapy use in women with breast cancer: A review of 169,329 patients from the American College of Surgeons' National Cancer Database.
Cancer Research.
2015
-
Abstract P5-15-07: Association of patient preference for adjuvant chemotherapy (chemo) at baseline (BL) with toxicity, mental health, function, quality of life (QoL) and survival in older women with early stage breast cancer (ESBC) [CALGB 49907 Alliance].
Cancer Research.
2015
-
Abstract P6-14-05: A novel link between anti-apoptotic signaling, NFκB, and SMAD7 in IBC pathobiology.
Cancer Research.
2015
-
Acculturation and Ethnic Variations in Breast Cancer Risk Factors, Gail Model Risk Estimates and Mammographic Breast Density.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology.
760-760.
2015
-
Abstract A41: Hypoxia-dependent modification of collagen networks promotes sarcoma metastasis.
Cancer Research.
A41-A41.
2015
-
Abstract PR09: A genome-wide RNAi screen reveals a protective role of decreased lipogenesis under hypoxia.
Cancer Research.
PR09-PR09.
2015
-
Abstract IA11: New insights into DNA double-strand break responses.
Cancer Research.
IA11-IA11.
2014
-
Abstract 1265: Carbohydrate intake, glycemic index and prostate cancer risk.
Cancer Research.
1265-1265.
2014
-
Abstract 1904: RNA expression based screening of ALK gene fusion from formalin fixed non-small cell lung cancer samples.
Cancer Research.
1904-1904.
2014
-
Abstract 2320: Clinical epigenetic resensitization of platinum-resistant, recurrent ovarian cancer patients with SGI-110, a novel, second-generation, subcutaneously administered hypomethylating agent (HMA).
Cancer Research.
2320-2320.
2014
-
Abstract 2674: Stroma biology identifies heparins as differentiating agents in neuroblastoma.
Cancer Research.
2674-2674.
2014
-
Abstract 2819: Efficacy and safety of the Ad-GM·CAIX dendritic cell-based vaccine in treatingin vivometastatic renal cell carcinoma compared to sunitinib monotherapy and simultaneous vaccine-sunitinib combination therapy.
Cancer Research.
2819-2819.
2014
-
Abstract 2970: Differential effects of caloric and carbohydrate restriction on prostate cancer in a mouse model.
Cancer Research.
2970-2970.
2014
-
Abstract 3283: GWAS identifies risk variants for mucinous ovarian carcinoma.
Cancer Research.
3283-3283.
2014
-
Abstract 3311: The cholesterol/ 27-hydroxycholesterol axis is a novel therapeutic target in castrate resistant prostate cancer.
Cancer Research.
3311-3311.
2014
-
Abstract 3536: Roles of miR-215 and regulatory mechanisms for its biogenesis in response to hypoxia in glioblastoma stem cells.
Cancer Research.
3536-3536.
2014
-
Abstract 3774: Hyperthermia treatment overcomes temozolomide resistance in glioma cells by downregulatingMGMTexpression and increasing temozolomide uptake.
Cancer Research.
3774-3774.
2014
-
Abstract 3841: Bevacizumab (BEV) and risk of arterial (ATE) and venous thromboembolism (VTE) in metastatic castration-resistant prostate cancer (mCRPC) patients treated on CALGB 90401(ALLIANCE).
Cancer Research.
3841-3841.
2014
-
Abstract 4117: Utilizing RNA aptamers for biomarker discovery in a novel cell culture system for hepatocellular carcinoma.
Cancer Research.
4117-4117.
2014
-
Abstract 4137: Latent class model characterization of neighborhood SES.
Cancer Research.
4137-4137.
2014
-
Abstract 4270: The use of mutational signatures in identifying carcinogen exposure.
Cancer Research.
4270-4270.
2014
-
Abstract 4481: Genetically encoded chimeric polypeptide nanoparticles for gemcitabine delivery to solid tumors.
Cancer Research.
4481-4481.
2014
-
Abstract 4518: The PI3K-δ inhibitor TGR-1202 induces cytotoxicity and inhibits phosphorylation of AKT in 17p deleted and non-17p deleted CLL cells in vitro.
Cancer Research.
4518-4518.
2014
-
Abstract 4570: Role of ERRalpha in ovarian cancer.
Cancer Research.
4570-4570.
2014
-
Abstract 4583: In situ photocontrolled intratumoral depot for combined photodynamic therapy and brachytherapy for solid tumor.
Cancer Research.
4583-4583.
2014
-
Abstract 4831: Breast cancer cells metastasize to bone through E-selectin+ vascular gateways.
Cancer Research.
4831-4831.
2014
-
Abstract 5168: Gastric adenocarcinomas show pervasive loss of heterozygosity and enrichment for “STOP” genes in regions of hemizygous deletion.
Cancer Research.
5168-5168.
2014
-
Abstract 518: Identification of differentially expressed microRNAs in human hepatocellular adenoma associated with type I glycogen storage disease: a potential utility as biomarkers.
Cancer Research.
518-518.
2014
-
Abstract 5447: Targeting vascular endothelial growth factor A and tumor hypoxia combined with radiation eradicates sarcomas through destruction of tumor vasculature and thwarting of the hypoxic response.
Cancer Research.
5447-5447.
2014
-
Abstract 63: Driving brain tumorigenesis: Generation of a mutant IDH1 mouse model of progressive glioma.
Cancer Research.
63-63.
2014
-
Abstract 946: Exome genotyping array identifies rare and low-frequency variants that may be associated with ovarian cancer risk.
Cancer Research.
946-946.
2014
-
Abstract CT238: Phase III randomized, placebo controlled trial of COX-2 inhibition in addition to standard chemotherapy for advanced non-small cell lung cancer (NSCLC):CALGB 30801 (Alliance).
Cancer Research.
CT238-CT238.
2014
-
Abstract LB-123: Novel function of STAT1 pathway as a modulator of tumor progression in serous papillary endometrial cancer.
Cancer Research.
2014
-
Abstract LB-167: Tumor cells, but not endothelial cells, mediate the eradication of primary cancers by radiation therapy.
Cancer Research.
2014
-
Abstract LB-89: Germ-line and somatic SMARCA4 mutations characterize small cell carcinoma of the ovary, hypercalcemic type.
Cancer Research.
2014
-
Abstract A25: GLI inhibition as a new strategy to treat lung squamous cell carcinoma..
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research.
A25-A25.
2014
-
Abstract P5-14-04: Preoperative single-fraction partial breast radiotherapy – Initial results from a novel phase I dose-escalation protocol with exploration of radiation response biomarkers.
Cancer Research.
2013
-
Abstract 1200: Molecular subtypes of gastric cancer show systematic differences in response to PI3K inhibitors and fluorouracil..
Cancer Research.
1200-1200.
2013
-
Abstract 1352: Epithelial-mesenchymal transition (EMT) gene variants influence epithelial ovarian cancer risk in women of European, African and Asian ancestry..
Cancer Research.
1352-1352.
2013
-
Abstract 1376: Exercise alters breast cancer phenotype through distinct reductions in host-derived proinflammatory growth factor ligands..
Cancer Research.
1376-1376.
2013
-
Abstract 2079: Antitumoral activity of INC280 against adult glioblastoma brain tumors xenografts..
Cancer Research.
2079-2079.
2013
-
Abstract 2564: Identification of a novel SPOP missense mutation from targeted next-generation sequencing of men with chromosome 17-q linkage..
Cancer Research.
2564-2564.
2013
-
Abstract 330A: Differential expression of angiogenic genes in invasive high grade serous ovarian carcinomas..
Cancer Research.
330A-330A.
2013
-
Abstract 352: Murine model of chordoma: Sonic Hedgehog promoter-driven Cre activation of Brachyury (T) expression induces spinal disk abnormalities and perinatal lethal developmental defects..
Cancer Research.
352-352.
2013
-
Abstract 3647: Dose-dependent alteration of CpG methylation inAHRRandGFI1in mononuclear cell DNA of smokers..
Cancer Research.
3647-3647.
2013
-
Abstract 364: Exercise slows tumor progression and normalizes tumor vasculature in murine models of breast cancer..
Cancer Research.
364-364.
2013
-
Abstract 3698: Inhibition of cholesterol uptake with ezetimibe reduces intra-tumoral testosterone levels and slows tumor growth in transgenic mouse models of prostate cancer..
Cancer Research.
3698-3698.
2013
-
Abstract 3914:In vivolabel-free examination of early-stage melanoma formation..
Cancer Research.
3914-3914.
2013
-
Abstract 4341: A novel injectable polymer liquid that self-assembles into radioactive “seeds” for brachytherapy..
Cancer Research.
4341-4341.
2013
-
Abstract 4479: Preclinical toxicology and pharmacology for BACPTDP, a camptothecin that targets hypoxic/acidic tumors..
Cancer Research.
4479-4479.
2013
-
Abstract 4509: Genetically encoded chimeric polypeptide nanoparticles for paclitaxel delivery to triple negative breast cancer..
Cancer Research.
4509-4509.
2013
-
Abstract 4707: Validation of survival prognostic models for non-small-cell lung cancer instage- and age-specific groups..
Cancer Research.
4707-4707.
2013
-
Abstract 4767: Preclinical mouse model of recurrent epithelial ovarian cancer..
Cancer Research.
4767-4767.
2013
-
Abstract 4850: Variation in circadian rhythm genes influence epithelial ovarian cancer risk and invasiveness..
Cancer Research.
4850-4850.
2013
-
Abstract 5041: The type III TGF-beta receptor promotes FGF2-mediated neuronal differentiation in neuroblastoma..
Cancer Research.
5041-5041.
2013
-
Abstract 510: Activation of PP2A by SET antagonism destabilizes c-Myc and inhibits breast cancer growth..
Cancer Research.
510-510.
2013
-
Abstract 5298: Two distinctive single nucleotide polymorphisms determine liver metastases responses to docetaxel plus thiotepa for metastatic breast cancer patients..
Cancer Research.
5298-5298.
2013
-
Abstract 5615: Evaluation of the antitumoral efficacy and toxicity of injectable, polymeric radionuclide seeds in a noninvasive preclinical prostate tumor model..
Cancer Research.
5615-5615.
2013
-
Abstract 5681: Modulation of Wnt/β-catenin signaling by niclosamide and related derivatives..
Cancer Research.
5681-5681.
2013
-
Abstract 951: Cross-resistance and re-sensitization to multiple drugs in an IBC model of lapatinib acquired resistance parallels redox adaptation..
Cancer Research.
951-951.
2013
-
Abstract LB-161: A phase I safety study of NPC-1C, a novel, therapeutic antibody to treat pancreas and colorectal cancers..
Cancer Research.
2013
-
Abstract LB-164: Treatment of advanced stage colorectal cancer with ETBX-011 immunotherapeutic..
Cancer Research.
2013
-
Abstract LB-296: FDG-PET avidity negatively impacts survival in pStage I NSCLC in the ACOSOG Z4031 trial..
Cancer Research.
2013
-
Predictors of Colorectal Cancer Surveillance among Radiation-treated Survivors of Childhood Cancer.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology.
478-478.
2013
-
Abstract 1027: Helicobacter pylori blood biomarkers for gastric cancer risk in the Shanghai Men's Health Study.
Cancer Research.
1027-1027.
2012
-
Abstract 1642: Rare missense variants inMAP3K14andARHGAP27in men with hereditary prostate cancer.
Cancer Research.
1642-1642.
2012
-
P4-10-10: Breast Cancer Risk Factors among Asian Versus Caucasian Women with BRCA1/2 Mutations..
Cancer Research.
2011
-
Abstract 3182: PTM ELISA microarray for breast cancer biomarker discovery.
Cancer Research.
3182-3182.
2011
-
Abstract 5569: The association between statin use and risk of biochemical recurrence in men treated with radical prostatectomy in a cohort of men with inherited forms of prostate cancer.
Cancer Research.
5569-5569.
2011